Suppr超能文献

SPLUNC1/BPIFA1 有助于宿主肺部抵抗肺炎克雷伯氏菌呼吸道感染。

SPLUNC1/BPIFA1 contributes to pulmonary host defense against Klebsiella pneumoniae respiratory infection.

机构信息

Department of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, PA 15260, USA.

出版信息

Am J Pathol. 2013 May;182(5):1519-31. doi: 10.1016/j.ajpath.2013.01.050. Epub 2013 Mar 15.

Abstract

Epithelial host defense proteins comprise a critical component of the pulmonary innate immune response to infection. The short palate, lung, nasal epithelium clone (PLUNC) 1 (SPLUNC1) protein is a member of the bactericidal/permeability-increasing (BPI) fold-containing (BPIF) protein family, sharing structural similarities with BPI-like proteins. SPLUNC1 is a 25 kDa secretory protein that is expressed in nasal, oropharyngeal, and lung epithelia, and has been implicated in airway host defense against Pseudomonas aeruginosa and other organisms. SPLUNC1 is reported to have surfactant properties, which may contribute to anti-biofilm defenses. The objective of this study was to assess the importance of SPLUNC1 surfactant activity in airway epithelial secretions and to explore its biological relevance in the context of a bacterial infection model. Using cultured airway epithelia, we confirmed that SPLUNC1 is critically important for maintenance of low surface tension in airway fluids. Furthermore, we demonstrated that recombinant SPLUNC1 (rSPLUNC1) significantly inhibited Klebsiella pneumoniae biofilm formation on airway epithelia. We subsequently found that Splunc1(-/-) mice were significantly more susceptible to infection with K. pneumoniae, confirming the likely in vivo relevance of this anti-biofilm effect. Our data indicate that SPLUNC1 is a crucial component of mucosal innate immune defense against pulmonary infection by a relevant airway pathogen, and provide further support for the novel hypothesis that SPLUNC1 protein prevents bacterial biofilm formation through its ability to modulate surface tension of airway fluids.

摘要

上皮宿主防御蛋白是肺部固有免疫反应对感染的重要组成部分。短腭、肺、鼻上皮克隆(PLUNC)1(SPLUNC1)蛋白是杀菌/通透性增加(BPI)折叠含(BPIF)蛋白家族的成员,与 BPI 样蛋白具有结构相似性。SPLUNC1 是一种 25 kDa 的分泌蛋白,在鼻、口咽和肺上皮中表达,被认为参与气道防御假单胞菌和其他生物体。据报道,SPLUNC1 具有表面活性剂特性,这可能有助于抗生物膜防御。本研究的目的是评估 SPLUNC1 表面活性剂活性在气道上皮分泌物中的重要性,并探索其在细菌感染模型中的生物学相关性。通过培养气道上皮细胞,我们证实 SPLUNC1 对维持气道液体内的低表面张力至关重要。此外,我们证明重组 SPLUNC1(rSPLUNC1)显著抑制了肺炎克雷伯菌在气道上皮上的生物膜形成。随后,我们发现 Splunc1(-/-)小鼠对肺炎克雷伯菌感染的敏感性显著增加,证实了这种抗生物膜作用的体内相关性。我们的数据表明,SPLUNC1 是一种重要的黏膜固有免疫防御成分,可抵抗相关气道病原体引起的肺部感染,并进一步支持 SPLUNC1 蛋白通过调节气道液体内的表面张力来防止细菌生物膜形成的新假说。

相似文献

引用本文的文献

2
The Acari Hypothesis, V: deciphering allergenicity.螨类假说,第五章:解读变应原性。
Front Allergy. 2024 Nov 1;5:1454292. doi: 10.3389/falgy.2024.1454292. eCollection 2024.
6
Antibiotic Resistant Biofilms and the Quest for Novel Therapeutic Strategies.抗生素耐药生物膜与新型治疗策略的探索
Indian J Microbiol. 2024 Mar;64(1):20-35. doi: 10.1007/s12088-023-01138-w. Epub 2023 Nov 28.

本文引用的文献

6
Inducible innate resistance of lung epithelium to infection.肺上皮细胞感染的诱导固有抗性。
Annu Rev Physiol. 2010;72:413-35. doi: 10.1146/annurev-physiol-021909-135909.
7
The clinical consequences of antimicrobial resistance.抗菌药物耐药性的临床后果。
Curr Opin Microbiol. 2009 Oct;12(5):476-81. doi: 10.1016/j.mib.2009.08.001. Epub 2009 Aug 27.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验